|
CALL
|
$216,000
|
1.6K
|
Q1 2025
Added 300.0%
|
|
|
PUT
|
$54,000
|
400
|
Q4 2024
Reduced 63.64%
|
|
|
CALL
|
$199,000
|
25.6K
|
Q1 2025
Reduced 69.23%
|
|
|
PUT
|
$224,000
|
28.8K
|
Q1 2025
Added 0.35%
|
|
|
CALL
|
$574,000
|
32.4K
|
Q1 2025
Reduced 66.56%
|
|
|
PUT
|
$1.73 Million
|
97.6K
|
Q1 2025
Reduced 28.29%
|
|
Inovio Pharmaceuticals Inc
|
CALL
|
$30,000
|
18.8K
|
Q1 2025
Reduced 63.92%
|
|
|
CALL
|
$2.95 Million
|
82.1K
|
Q1 2025
Added 24.96%
|
|
|
PUT
|
$448,000
|
12.5K
|
Q1 2025
Added 73.61%
|
|
|
CALL
|
$102,000
|
12K
|
Q1 2025
Reduced 84.04%
|
|
|
CALL
|
$191,000
|
23.5K
|
Q1 2025
Reduced 7.48%
|
|
|
PUT
|
$4,000
|
600
|
Q1 2025
Reduced 97.86%
|
|
|
CALL
|
$2.52 Million
|
33K
|
Q1 2025
Reduced 64.09%
|
|
|
PUT
|
$1.15 Million
|
15.1K
|
Q1 2025
Reduced 72.6%
|
|
|
CALL
|
$159,000
|
1K
|
Q1 2025
Reduced 85.29%
|
|
|
PUT
|
$191,000
|
1.2K
|
Q1 2025
Reduced 89.19%
|
|
International Seaways Inc
|
CALL
|
$268,000
|
8.1K
|
Q1 2025
Added 19.12%
|
|
International Seaways Inc
|
PUT
|
$112,000
|
3.4K
|
Q1 2025
Reduced 10.53%
|
|
|
CALL
|
$163,000
|
2.8K
|
Q1 2025
Added 250.0%
|
|
|
PUT
|
$46,000
|
800
|
Q1 2025
New holding
|
|
|
CALL
|
$43,000
|
8K
|
Q1 2025
Added 2566.67%
|
|
|
PUT
|
$57,000
|
10.5K
|
Q1 2025
Reduced 78.57%
|
|
|
CALL
|
$7,000
|
1.1K
|
Q1 2025
Reduced 45.0%
|
|
|
PUT
|
$2,000
|
400
|
Q1 2025
New holding
|
|
|
PUT
|
$1,000
|
100
|
Q1 2025
New holding
|
|
|
CALL
|
$4.16 Million
|
120K
|
Q1 2025
Added 1095.0%
|
|
|
PUT
|
$372,000
|
10.7K
|
Q1 2025
Reduced 91.5%
|
|
Innovex International Inc
|
PUT
|
$17,000
|
1K
|
Q1 2025
Added 400.0%
|
|
|
CALL
|
$354,000
|
543K
|
Q1 2025
Added 165.83%
|
|
|
PUT
|
$240,000
|
369K
|
Q1 2025
Added 43.65%
|
|
Ionis Pharmaceuticals Inc
|
CALL
|
$1.18 Million
|
39.2K
|
Q1 2025
Reduced 24.18%
|
|
Ionis Pharmaceuticals Inc
|
PUT
|
$1.16 Million
|
38.5K
|
Q1 2025
Reduced 23.0%
|
|
|
PUT
|
$6.73 Million
|
176K
|
Q1 2025
Reduced 37.7%
|
|
Iovance Biotherapeutics Inc
|
CALL
|
$1.57 Million
|
471K
|
Q1 2025
Reduced 29.43%
|
|
Iovance Biotherapeutics Inc
|
PUT
|
$531,000
|
160K
|
Q1 2025
Reduced 64.62%
|
|
Immunoprecise Antibodies LTD
|
CALL
|
$10,000
|
28.3K
|
Q1 2025
New holding
|
|
Immunoprecise Antibodies LTD
|
PUT
|
$0
|
100
|
Q1 2025
New holding
|
|
|
CALL
|
$273,000
|
2.4K
|
Q1 2025
Reduced 42.86%
|
|
|
PUT
|
$102,000
|
900
|
Q1 2025
Reduced 75.68%
|
|
Interpublic Group Cos Inc
|
CALL
|
$860,000
|
31.7K
|
Q1 2025
Reduced 79.69%
|
|
Interpublic Group Cos Inc
|
PUT
|
$40,000
|
1.5K
|
Q1 2025
Reduced 80.26%
|
|
|
CALL
|
$12,000
|
200
|
Q4 2024
Reduced 50.0%
|
|
|
PUT
|
$12,000
|
200
|
Q1 2025
New holding
|
|
|
CALL
|
$214,000
|
7.3K
|
Q1 2025
Added 305.56%
|
|
|
PUT
|
$117,000
|
4K
|
Q1 2025
Added 66.67%
|
|
Renaissance Cap Greenwich Fd
|
CALL
|
$7,000
|
200
|
Q1 2025
New holding
|
|
|
CALL
|
$1.47 Million
|
650K
|
Q1 2025
Reduced 50.75%
|
|
|
PUT
|
$2.57 Million
|
1.14M
|
Q1 2025
Added 103.55%
|
|
|
CALL
|
$1.08 Million
|
6.1K
|
Q1 2025
Reduced 66.85%
|
|
|
PUT
|
$6.19 Million
|
35.1K
|
Q1 2025
Added 202.59%
|
|